Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian Thompson

Showing results (71-80 of 109) with videos related to

Pageof 11
Sort By:
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|September 5, 2006
Relative value of repeat gastric ulcer surveillance gastroscopy in diagnosing gastric cancerA Neil Hopper, Michael R Stephens, Wyn G Lewis, et al.
Antimicrobial Agents and Chemotherapy|August 31, 2006
Molecular mechanism of a thumb domain hepatitis C virus nonnucleoside RNA-dependent RNA polymerase inhibitorAnita Y M Howe, Huiming Cheng, Ian Thompson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 18, 2012
Screening for prostate cancer with prostate-specific antigen testing: American Society of Clinical Oncology Provisional Clinical OpinionEthan Basch, Thomas K Oliver, Andrew Vickers, et al.
The Journal of Urology|August 19, 2008
Predicting prostate cancer risk through incorporation of prostate cancer gene 3Donna Pauler Ankerst, Jack Groskopf, John R Day, et al.
Cancer|January 26, 2005
The association of body mass index and prostate-specific antigen in a population-based studyJacques Baillargeon, Brad H Pollock, Alan R Kristal, et al.
Retina (Philadelphia, Pa.)|October 5, 2019
VASOPROLIFERATIVE TUMORS IN INTERMEDIATE UVEITISFrancesco Pichi, Piergorgio Neri, Aniruddha Agarwal, et al.
European Urology|September 22, 2018
A Prospective Adaptive Utility Trial to Validate Performance of a Novel Urine Exosome Gene Expression Assay to Predict High-grade Prostate Cancer in Patients with Prostate-specific Antigen 2-10ng/ml at Initial BiopsyJames McKiernan, Michael J Donovan, Eric Margolis, et al.
Clinical Chemistry|November 30, 2012
The Early Detection Research Network's Specimen reference sets: paving the way for rapid evaluation of potential biomarkersZiding Feng, Jacob Kagan, Margaret Pepe, et al.
Journal of Oncology Practice|January 2, 2013
Prostate-specific antigen test for prostate cancer screening: American Society of Clinical Oncology provisional clinical opinionRobert K Nam, Thomas K Oliver, Andrew J Vickers, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 7, 2004
A Phase I pharmacokinetic and biological correlative study of oblimersen sodium (genasense, g3139), an antisense oligonucleotide to the bcl-2 mRNA, and of docetaxel in patients with hormone-refractory prostate cancerAnthony W Tolcher, John Kuhn, Garry Schwartz, et al.
Pageof 11

Showing results (71-80 of 109) with videos related to

Sort By:
Pageof 11
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|September 5, 2006
Relative value of repeat gastric ulcer surveillance gastroscopy in diagnosing gastric cancerA Neil Hopper, Michael R Stephens, Wyn G Lewis, et al.
Antimicrobial Agents and Chemotherapy|August 31, 2006
Molecular mechanism of a thumb domain hepatitis C virus nonnucleoside RNA-dependent RNA polymerase inhibitorAnita Y M Howe, Huiming Cheng, Ian Thompson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 18, 2012
Screening for prostate cancer with prostate-specific antigen testing: American Society of Clinical Oncology Provisional Clinical OpinionEthan Basch, Thomas K Oliver, Andrew Vickers, et al.
The Journal of Urology|August 19, 2008
Predicting prostate cancer risk through incorporation of prostate cancer gene 3Donna Pauler Ankerst, Jack Groskopf, John R Day, et al.
Cancer|January 26, 2005
The association of body mass index and prostate-specific antigen in a population-based studyJacques Baillargeon, Brad H Pollock, Alan R Kristal, et al.
Retina (Philadelphia, Pa.)|October 5, 2019
VASOPROLIFERATIVE TUMORS IN INTERMEDIATE UVEITISFrancesco Pichi, Piergorgio Neri, Aniruddha Agarwal, et al.
European Urology|September 22, 2018
A Prospective Adaptive Utility Trial to Validate Performance of a Novel Urine Exosome Gene Expression Assay to Predict High-grade Prostate Cancer in Patients with Prostate-specific Antigen 2-10ng/ml at Initial BiopsyJames McKiernan, Michael J Donovan, Eric Margolis, et al.
Clinical Chemistry|November 30, 2012
The Early Detection Research Network's Specimen reference sets: paving the way for rapid evaluation of potential biomarkersZiding Feng, Jacob Kagan, Margaret Pepe, et al.
Journal of Oncology Practice|January 2, 2013
Prostate-specific antigen test for prostate cancer screening: American Society of Clinical Oncology provisional clinical opinionRobert K Nam, Thomas K Oliver, Andrew J Vickers, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 7, 2004
A Phase I pharmacokinetic and biological correlative study of oblimersen sodium (genasense, g3139), an antisense oligonucleotide to the bcl-2 mRNA, and of docetaxel in patients with hormone-refractory prostate cancerAnthony W Tolcher, John Kuhn, Garry Schwartz, et al.
Pageof 11